Stay updated on PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.

Latest updates to the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThis updates the ClinicalTrials.gov page’s displayed revision version from v3.5.2 to v3.5.3, indicating a minor application/version update rather than a change to the trial record itself.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded revision v3.5.0 to the Record History and removed revision v3.4.3 from the history.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded revision v3.4.3 to the history and removed v3.4.2 from the log.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision entry (v3.4.2) was added and a funding-status notice was removed; these are administrative updates to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check95 days agoChange DetectedA site-wide funding/status notice was added, informing users about potential delays and that the NIH Clinical Center is open. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.9%

Stay in the know with updates to PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.